ARTICLE | Clinical News
Calcilytics: Began Clinical Trial
December 18, 2000 8:00 AM UTC
NPS Pharmaceuticals Inc. (NPSP; TSE:NX), Salt Lake City, Utah Product: Calcilytics Business: Musculoskeletal Therapeutic category: Receptor antagonist Target: Calcium receptors on parathyroid cells De...